Had You Invested $1,000 in Goldman Sachs 10 Years Ago, Here's What You'd Have Now — Neutral
GS 24/7 Wall Street — April 13, 2026Goldman Sachs (NYSE: GS) reported Q1 2026 EPS of $17.55 versus a FactSet estimate of $16.47, with revenue of $17.23 billion, up 14%, against a $16.99 billion estimate.
IVZ's March AUM Declines 4.4% on Money Market Outflows & Weak Markets — Negative
IVZ Zacks Investment Research — April 13, 2026Invesco's March AUM falls to $2.16T as market losses and outflows hurt, even as long-term inflows stayed positive.
Down 15.4% in 4 Weeks, Here's Why Veeva (VEEV) Looks Ripe for a Turnaround — Positive
VEEV Zacks Investment Research — April 13, 2026Veeva (VEEV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Amazon (NASDAQ:AMZN | AMZN Price Prediction) trades at $233.65 as of writing.
Adecoagro (AGRO) Just Reclaimed the 20-Day Moving Average — Positive
AGRO Zacks Investment Research — April 13, 2026After reaching an important support level, Adecoagro (AGRO) could be a good stock pick from a technical perspective. AGRO surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
After Plunging 26.5% in 4 Weeks, Here's Why the Trend Might Reverse for Guidewire Software (GWRE) — Negative
GWRE Zacks Investment Research — April 13, 2026The heavy selling pressure might have exhausted for Guidewire Software (GWRE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Down 41% in 4 Weeks, Here's Why You Should You Buy the Dip in Angel Studios, Inc. (ANGX) — Positive
ANGX Zacks Investment Research — April 13, 2026Angel Studios, Inc. (ANGX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Jack Henry (JKHY) Loses 12.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner — Negative
JKHY Zacks Investment Research — April 13, 2026Jack Henry (JKHY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
YPF Sociedad Anonima (YPF) Just Flashed Golden Cross Signal: Do You Buy? — Positive
YPF Zacks Investment Research — April 13, 2026YPF Sociedad Anonima (YPF) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, YPF crossed above the 20-day moving average, suggesting a short-term bullish trend.
After Plunging 15.0% in 4 Weeks, Here's Why the Trend Might Reverse for Workiva (WK) — Negative
WK Zacks Investment Research — April 13, 2026The heavy selling pressure might have exhausted for Workiva (WK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Brookfield: An Undervalued Compounder With 20%+ Annual Earnings Growth Potential — Positive
BN Seeking Alpha — April 13, 2026Brookfield Corporation targets 20%+ annual core earnings growth through 2030, with upside to 25% from carried interest and capital allocation. BN's high-margin, fee-based asset management and rapidly scaling insurance platform are dual engines driving recurring, compounding earnings. Asset management is the most predictable segment, with $603 billion in fee-bearing capital and $3 billion in annual fee-related earnings, supporting stable long-term growth.
Portnoy Law Firm Announces Class Action on Behalf of Trip.com Group Limited Investors — Neutral
TCOM GlobeNewsWire — April 13, 2026LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Trip.com Group Limited, (“Trip.com” or the "Company") (NASDAQ:TCOM) investors off a class action on behalf of investors that bought securities between April 30, 2024 and January 13, 2026, inclusive (the “Class Period”). Trip.com investors have until May 11, 2026 to file a lead plaintiff motion.
Portnoy Law Firm Announces Class Action on Behalf of Driven Brands Holdings, Inc. Investors — Neutral
DRVN GlobeNewsWire — April 13, 2026LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Driven Brands Holdings, Inc., (“Driven Brands” or the "Company") (NASDAQ: DRVN) investors off a class action on behalf of investors that bought securities between May 9, 2023 and February 24, 2026, inclusive (the “Class Period”). Driven Brands investors have until May 8, 2026 to file a lead plaintiff motion.
Revolution Medicines Inc (NASDAQ:RVMD) stock is brushing off the broad market selloff this morning, last seen up 35.5% to trade at $131.35, and earlier hitting a record high of $135.81.
Analyst: High Memory Costs Pose Risk to Best Buy Stock — Negative
BBY Schaeffers Research — April 13, 2026Best Buy Co Inc (NYSE:BBY) is 3% lower to trade at $60.50 at last glance, after a Goldman Sachs downgraded the retail stock to "sell" from "buy," and cut its price-target cut to a Street-low $59 from $76.
Portnoy Law Firm Announces Class Action on Behalf of Concorde International Group, Ltd. Investors — Neutral
CIGL GlobeNewsWire — April 13, 2026LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Concorde International Group, Ltd., (“Concord” or the "Company") (NASDAQ:CIGL) investors of a class action on behalf of investors that bought securities between April 21, 2025 and July 14, 2025, inclusive (the “Class Period”). Concord investors have until May 18, 2026 to file a lead plaintiff motion.
Portnoy Law Firm Announces Class Action on Behalf of Soleno Therapeutics, Inc. Investors — Neutral
SLNO GlobeNewsWire — April 13, 2026LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Soleno Therapeutics, Inc., (“Soleno” or the “Company”) (NASDAQ: SLNO) investors off a class action on behalf of investors that bought securities between March 6, 2025 and November 4, 2025, inclusive (the “Class Period”). Soleno investors have until May 5, 2026 to file a lead plaintiff motion.
Portnoy Law Firm Announces Class Action on Behalf of Coty, Inc. Investors — Neutral
COTY GlobeNewsWire — April 13, 2026LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Coty, Inc., (“COTY” or the "Company") (NYSE: COTY) investors of a class action on behalf of investors that bought securities between November 5, 2025 and February 4, 2026, inclusive (the “Class Period”). Coty investors have until May 22, 2026 to file a lead plaintiff motion.
After a Rough March, Municipal Bonds May Be Offering Value — Positive
MNBD ETF Trends — April 13, 2026The Ides of March came calling for municipal bonds. State- and city-issued debt joined gold and consumer staples stocks as asset classes that betrayed their safe-haven reputations in March.
Portnoy Law Firm Announces Class Action on Behalf of Oddity Tech, Ltd. Investors — Neutral
ODD GlobeNewsWire — April 13, 2026LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Oddity Tech, Ltd, (“Oddity” or the "Company") (NASDAQ:ODD) investors off a class action on behalf of investors that bought securities between February 26, 2025 and February 24, 2026, inclusive (the “Class Period”). Oddityinvestors have until May 11, 2026 to file a lead plaintiff motion.